Farmacias Benavides, S.A.B. de C.V. Stock

Equities

BEVIDES B

MXP3895X1106

Drug Retailers

End-of-day quote Mexican S.E. 06:00:00 2024-04-07 pm EDT 5-day change 1st Jan Change
18.9 MXN -0.53% Intraday chart for Farmacias Benavides, S.A.B. de C.V. 0.00% -0.53%
Sales 2021 14.74B 864M Sales 2022 16.22B 951M Capitalization 3.69B 216M
Net income 2021 9M 528K Net income 2022 127M 7.45M EV / Sales 2021 0.43 x
Net Debt 2021 2.67B 156M Net Debt 2022 2.56B 150M EV / Sales 2022 0.39 x
P/E ratio 2021
382 x
P/E ratio 2022
29 x
Employees 7,956
Yield 2021 *
-
Yield 2022
-
Free-Float 16.07%
More Fundamentals * Assessed data
Dynamic Chart
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Farmacias Benavides, S.A.B. De C.V. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Farmacias Benavides, S.A.B. De C.V. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Farmacias Benavides, S.A.B. De C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Alliance Boots GmbH completed the acquisition of 0.94% stake in Farmacias Benavides, S.A.B. de C.V. (BMV:BEVIDES B) for MXN 51.2 million. CI
Farmacias Benavides, S.A.B. de C.V.'s Equity Buyback announced on November 4, 2014, has expired. CI
Farmacias Benavides, S.A.B. de C.V. (BMV:BEVIDES B) announces an Equity Buyback for 17,890,701 shares, representing 4.38% for MXN 238.84 million. CI
More news
1 day-0.53%
Current month-0.53%
1 month-0.53%
3 months-0.53%
6 months-0.53%
Current year-0.53%
More quotes
1 month
18.90
Extreme 18.9
19.00
Current year
18.90
Extreme 18.9
19.00
1 year
8.30
Extreme 8.3
19.00
3 years
8.30
Extreme 8.3
19.00
5 years
8.30
Extreme 8.3
19.00
10 years
8.30
Extreme 8.3
19.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-12-01
Director of Finance/CFO - -
Corporate Secretary - 17-04-02
Members of the board TitleAgeSince
Director/Board Member 68 16-12-31
Chief Executive Officer - 22-12-01
Director/Board Member - 13-12-31
More insiders
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
More about the company
  1. Stock Market
  2. Equities
  3. BEVIDES B Stock